ment, on long term octreotide therapy. Co-morbidities included hypertension and ischaemic heart disease. Anaesthetic technique: Af ter placement of a radial arterial catheter, anaesthesia was induced with midazolam, fentanyl and propofol. Af ter administering pancuronium, the trachea was intubated and anaesthesia maintained with sevoflurane, and a fentanyl infusion for analgesia. Further monitoring was placed; a central venous catheter, pulmonary artery catheter and transesophageal echocardiography (TOE) . An octreotide infusion at 50mcg/hr was commenced, and was available as bolus in the event of refractory hypotension. Antifibrinoly tic therapy consisted of aprotinin administered intravenously and into the cardiopulmonary bypass (CPB) circuit. The patient was weaned of f CPB with vasopressin and milrinone infusions with no evidence of carcinoid crisis throughout. Discussion: The aim of the anaesthetic technique is minimising factors that may precipitate a carcinoid crisis, its prompt recognition, and pharmacological management of a low cardiac output state. It is vital to establish monitoring to predict the onset of haemodynamic instability. The mainstay of perioperative treatment is with octreotide, which is ef fective in managing manifestations of carcinoid activity and stabilizing haemodynamics. The use of agents that precipitate histamine release or exacerbate catecholamine secretion should be avoided. Aprotinin is used to reduce blood loss, but may also reduce carcinoid tumour ef fects through actions on the kallikrein-kinin system. References: Learning points: Cardiac surgery for carcinoid heart disease can be complicated by haemodynamic instability secondary to carcinoid crises and cardiovascular dysfunction. We highlight the importance of acknowledgement of potential challenges, preoperative preparation, and appropriate drug therapy.
4AP6-11
Valsalva like maneuver with ventilator to treat supraventricular tachycardia Carneiro S., Pereira M., Pereira G., Antunes C.
Hospital de Braga, Dept of Anaesthesiology, Braga, Por tugal
Background: Life-threatening cardiovascular events under anaesthesia are uncommon. However, intra-operative dysrrhy thmias af fect many patients undergoing non-cardiac surgery 1 . We report a successful intraoperative treatment of a regular supraventricular tachycardia (SVT) with a Valsalva like maneuver carried on by ventilator. Case report: Female patient, 42 years old, 60kg, ASA I, was admit ted for elective tympanoplasty. The patient was pre-treated with 2mg of midazolam and monitored according to ASA standards. We performed a balanced anesthesia with fentanyl (3µ/kg), propofol (3mg/kg) and rocuronium (0.6mg/kg) as induction. Anesthetic maintenance with sevoflurane. Fif teen minutes af ter induction and before surgical incision the patient developed a regular SVT with a ma ximum heart rate of 155 bpm without changes in blood pressure. A Valsalva like maneuver was performed using the ventilator with mechanical ventilation initially applying PEEP 30cmH2O and maintained for about 15 seconds. When it was suddenly withdrawn PEEP and heart rate decrease to 130bpm. Af ter this, we switched to spontaneous ventilation, placing the APL valve at 40 cm H2O and sustained the balloon compressed for about 15 seconds. Af ter this maneuver there was a gradual decline in heart rate up to 88 bpm. The patient maintained hemodynamic stability (rhy thmic and blood pressure) and therefore was decided to proceed with the surgery, which took place without any complications. Discussion: If the patient is haemodynamically stable, the initial management of regular SVT should include vagal maneuvers 2 . In anesthetized patients, without access to the carotid sinus, pharmacological treatment is of ten the first choice in SVT. However, the Valsalva maneuver induces a temporary slowing of sino-atrial nodal activity and atrio-ventricular nodal conduction by stimulating baroreceptors in the aorta, which triggers a reflex increase in vagus nerve activity and sympathetic withdrawal. With increasing PEEP and balloon compression we can stimulate aortic baroreceptors simulating a Valsalva maneuver. Additionally, we believe that Bainbridge reflex took place too, with initial high PEEP applied. References: 1. Circulation. 2007; 116:e418-e500 2. Resuscitation. 2010; 81:1219-76 Learning points: A Valsalva like maneuver using the ventilator in anesthetized patients may be ef fective in treating regular SVT in the intraoperative set ting. Background and Goal of Study: Xenon anaesthesia has been repeatedly shown to exhibit a favourable and unique haemodynamic profile. Moreover, xenon conveys remarkable cardio-and neuroprotective ef fects in animal experiments. These properties could render xenon an at tractive anaesthetic agent in of f pump coronary artery bypass surgery (OPCAB). We hypothesized that xenon anaesthesia is non-inferior to sevoflurane anaesthesia with regard to haemodynamic stability during OPCAB surgery. Materials and Methods: Af ter obtainment of ethical commit tee approval and writ ten informed consent, 42 patients undergoing elective OPCAB surgery were enrolled. Patients were randomized to receive balanced anaesthesia with either xenon (50-60 vol.-%) or sevoflurane (1.1-1.4 vol.-%). Anaesthesia was titrated to maintain a bispectral index value between 40-60. Primary outcome parameter was the intraoperative use of vasopressors that were required to achieve pre-defined haemodynamic goals. Secondary outcomes included feasibility and safety criteria, including the incidence of postoperative delirium (POD). Haemodynamics were continuously monitored using a pulmonary artery catheter. While it was technically impossible to blind the at tending anaesthesiologist, research staf fs blinded to treatment allocation performed pre-and postoperative visits. Results and Discussion: Groups did not dif fer with respect to baseline characteristics and surgical parameters. In addition, intraoperative fluid balance, respiratory profile, depth of anaesthesia and heart rate were similar in both groups. However, in order to maintain a mean arterial blood pressure of >65mmHg, patients in the sevoflurane group required significantly higher norepinephrine doses (median (IQR): 0.07(0.06) vs. 0.02(0.01) µg•kg -1 •min -1 , p<0.0001). Area under the curves for intraoperative cardiac index (2.9(0.9) vs. 2.4(0.8) L•min -1 •m -2 , p<0.033) and stroke volume index (45.4(14.4) vs. 40.2(12.2) mL•m -2 , p<0.014) were significantly higher in the xenon-than in the sevoflurane group. Patients in the sevoflurane group had a significantly higher incidence of POD (38% vs. 9.5%, p<0.044). No dif ferences were noticed with respect to intraoperative safety parameters.
4AP7-1 Xenon anaesthesia in patients undergoing of f-pump coronary artery bypass graf t surgery: a prospective, randomized controlled clinical trial (EudraCT 2012-002316-12)

Conclusion(s):
Xenon-anaesthesia is safe and feasible in patients undergoing OPCAB-surgery. In addition, xenon anaesthesia was associated with a superior haemodynamic profile in these high-risk patients and with a lower incidence of POD.
4AP7-2
The predictors of hemodynamic recovery af ter rapid pacing for valve deployment in transcatheter aortic valve implantation Background and Goal of Study: Transcatheter aortic valve implantation (TAVI) is favored as a low invasive treatment for high-risk patients with severe aortic stenosis (AS). However some procedures during TAVI, including rapid pacing (RP), cause hemodynamic instability. We aimed to identif y the predictors of the prolonged hemodynamic compromise af ter RP for valve deployment in TAVI. Population and Methods: The patients with severe AS who underwent TAVI with SAPIEN/SAPIEN XT bioprosthesis (Edwards Lifescience, USA) between October 2009 and August 2013 in our institute were enrolled into the study. The preoperative demographic data, comorbidities, echocardiographic data and the hemodynamic parameters before and af ter valve deployment were reviewed retrospectively. Time af ter the end of RP until systolic arterial pressure (SAP) and mixed venous oxygen saturation (SvO2) recover (SAP>90mmHg and SvO2>65% simultaneously) was defined as the recovery time (RT). We classified the population into two groups by 75% quartile of RT in all patients: the early recovery group (ER) and the delayed recovery group (DR), and investigated the predictors of delayed hemodynamic recovery by multivariate logistic regression model. Results and discussion: 44patients were classified into two groups according to 75% quartile of RT(85.5sec): ER (RT < 85.5 sec, n=33) and DR (RT> 85.5sec, n=11) . The DR group had significantly smaller body surface area (p< 0.05) and lef t ventricular diameter (p< 0.05), and more complicated with intraventricular out flow obstruction, and lower SvO2 immediately before RP . The multivariate logistic regression model identified SvO2 as an independent predictor of the delayed recovery af ter RP (OR 0.767, 
4AP7-3
Transcatheter aortic valve implementation (TAVI): short-and long-term outcomes with respect to the type of procedure and the anaesthetic management Background and Goal of Study: Lit tle is known about long-term outcomes following TAVI.We compared the short-and long-term outcomes between 3 types of TAVI:Transfemoral with general anaesthesia (GA) or Local Anaesthesia/Sedation (LASedation) and Transapical. Materials and methods: 176 patients undergoing TAVI between January 2009 and June 2013 were retrospectively analyzed. Follow-up(FU) was completed in November 2013.Nonparametric tests were applied to compare the 3 groups.Survival was analyzed with Kaplan-Meier method.All data are expressed as median(IQR). Results and discussion: 4 patients in the LAS group were converted to GA (2 subjects were not cooperative and in other 2 vascular complications required surgical repair). 5 subjects in the Transapical group required postoperative dialysis vs no patients in the other groups (P < 0,001). The overall median survival rate at the ma ximum FU(55 months) is estimated at 32%(95%CI:25%-38%). Survival between groups was not significantly dif ferent.
GA(N=51) LASedation(N=66) Transapical(N=59)
Age; Y 86(83-89) 85(82-88) 84(80-88) EuroSCOREII 5, 4(1, 9) 5,1(2,1-8,1) 8,1(4-12,2)* Creatinine; mg/dL 1.2(0.9-1.6) 1. 
4AP7-4
Predictors of postoperative delirium af ter transcatheter aortic valve implementation (TAVI) 
